Ublituximab
TG1101-RMS-201
Approved mab active
Quick answer
Ublituximab for Multiple Sclerosis is a Approved program (mab) at TG THERAPEUTICS, INC. with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Multiple Sclerosis
- Phase
- Approved
- Modality
- mab
- Status
- active